Achieve Life Sciences (ACHV) Net Equity Issued and Repurchased (2012 - 2020)

Achieve Life Sciences (ACHV) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $9.0 million in Q4 2020.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $9.0 million in Q4 2020, while the trailing twelve-month figure through Dec 2021 was $9.0 million (down 1.91% YoY) and the FY2021 annual result came in at $21.3 million, up 35.18% from the prior year.
• Net Equity Issued and Repurchased advanced to $9.0 million in Q4 2020, from -$1000.0 in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $9.0 million in Q4 2020 to a low of -$1.1 million in Q4 2017.
• A 3-year average of $1.8 million and a median of $175000.0 in 2018 frame the typical range for Net Equity Issued and Repurchased.
• The widest YoY moves for Net Equity Issued and Repurchased: up 99.91% in 2018, down 99.91% in 2018.
• Tracing ACHV's Net Equity Issued and Repurchased over 3 years: stood at -$1.1 million in 2017, then soared by 99.91% to -$1000.0 in 2018, then jumped by 896800.0% to $9.0 million in 2020.
• The last three Net Equity Issued and Repurchased figures came in at $9.0 million (Q4 2020), -$1000.0 (Q4 2018), and $175000.0 (Q2 2018), per Business Quant data.